A US federal appeals court has temporarily halted the mail delivery of Mifepristone, a drug widely used in abortion procedures across the country.
The decision was issued on Friday by a three-judge panel of the Fifth Circuit Court of Appeals, following a legal challenge brought by the state of Louisiana.
Mifepristone is a key component in medication abortions and accounts for a majority of such procedures in the United States. The ruling, though temporary, is expected to have significant implications for access to abortion services, particularly in states with restrictive laws.
Louisiana, which filed the lawsuit, enforces some of the strictest anti-abortion measures in the country and has been at the forefront of legal battles over reproductive rights.
Legal analysts say the case could set the stage for further judicial review, potentially reaching higher courts as the debate over abortion access continues to intensify nationwide.
